AmeriServ Wealth Advisors’s GSK GSK Stock Holding History

AmeriServ Wealth Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-5,553	Closed	-$299K	–	55
2016 Q3	$299K	Buy	+5,553	New	+$304K	0.38%	52
2015 Q4	–	Sell	-6,256	Closed	-$301K	–	39
2015 Q3	$301K	Buy	6,256 +242	+4%	+$12.6K	0.57%	41
2015 Q2	$313K	Sell	6,014 -163	-3%	-$9.18K	0.36%	56
2015 Q1	$356K	Sell	6,177 -5,861	-49%	-$336K	0.41%	55
2014 Q4	$643K	Buy	12,038 +731	+6%	+$40.9K	0.62%	42
2014 Q3	$650K	Sell	11,307 -243	-2%	-$14.9K	1.12%	27
2014 Q2	$772K	Sell	11,550 -356	-3%	-$24.1K	0.83%	28
2014 Q1	$795K	Sell	11,906 -3,229	-21%	-$218K	0.8%	34
2013 Q4	$1.01M	Buy	15,135 +2,749	+22%	+$178K	0.6%	49
2013 Q3	$777K	Sell	12,386 -119	-1%	-$7.66K	0.49%	63
2013 Q2	$781K	Buy	+12,505	New	+$794K	0.5%	57

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AmeriServ Wealth Advisors's GSK Position: Q4 2016 in Review

AmeriServ Wealth Advisors sold out of GSK (GSK) in Q4 2016, closing a stake of 5,553 shares — an estimated $299K sold.

AmeriServ Wealth Advisors first reported a position in GSK in Q2 2013 and held it in 11 quarters. The position peaked at $1.01M in Q4 2013. 762 funds tracked by Wall St. Rank hold GSK as of Q4 2016.

AmeriServ Wealth Advisors reported no remaining GSK position as of Q4 2016 after selling out during the quarter.
AmeriServ Wealth Advisors sold 5,553 GSK shares in Q4 2016, an estimated $299K.
AmeriServ Wealth Advisors first reported a position in GSK in Q2 2013 and held it in 11 quarters.
AmeriServ Wealth Advisors's GSK position peaked at $1.01M in Q4 2013.
762 funds tracked by Wall St. Rank held GSK as of Q4 2016.

Based on AmeriServ Wealth Advisors's 13F filing for Q4 2016, filed 30 Jan 2017.